Non-immune hydrops fetalis
M R C O G PA R T 2 · S O S P O C K E T C A R D · K N O W L E D G E A R E A 5 – A N T E N ATA L C A R E
Non-Immune Hydrops Fetalis: A Practical Guide for Obstetricians Khairudin D et al. Non-immune hydrops fetalis: a practical guide for obstetricians. TOG 2023;25:110–120. doi:10.1111/tog.12862
1:2000 >90% 60% PREGNANCIES AFFECTED BY NIHF OF HYDROPS FETALIS IS NON-IMMUNE CAUSE FOUND PRENATALLY (+29% WITH ES)
DO N' T-M IS S FA C TS
-
HF diagnosis needs ≥2 fluid compartments; organ-fluid findings (e.g. hydronephrosis, ventriculomegaly) do not count
-
NIHF = >90% of hydrops; affects 1:2000 pregnancies; up to 60% perinatal mortality
-
ES adds ~30% diagnostic yield after normal CMA – part of NHS England R21 pathway
-
MCA PSV >1.5 MoM → FBS to confirm/treat fetal anaemia; 2nd/3rd trimester HF = fetal medicine emergency, tertiary review within 24h
-
Termination under Ground E; feticide advised >21+6 weeks
-
Maternal mirror syndrome = pre-eclampsia-like picture + anaemia/haemodilution (not haemoconcentration); resolves only with delivery/NIHF resolution
-
Deliver from 34 weeks (steroids if worsening) or term 37–38 weeks if stable, in a level III neonatal unit
-
Placental thickness ≥5 cm = placentomegaly; ‘ground glass’ appearance may indicate chorangioma
CAUSE BY TRIMESTER (DOMINANT)
1st: chromosomal (70%) 2nd: chromosomal 20% + monogenic (ES: up to 40%), infection 20%
3rd: genetic up to 25% (mostly monogenic), cardiovascular up to 25%
ABBREVIATION KEY
NIHF — non-immune hydrops fetalis sFlt-1 — soluble FMS-like tyrosine kinase 1
HF — hydrops fetalis GGT — gamma glutamyl transferase
CMA — chromosomal microarray analysis UA PI — umbilical artery pulsatility index
ES — exome sequencing TTTS — twin-twin transfusion syndrome
PCR — polymerase chain reaction TAPS — twin anaemia polycythaemia sequence
CVS — chorionic villus sampling TRAP — twin reversed arterial perfusion sequence
FBS — fetal blood sampling HLHS — hypoplastic left heart syndrome
MCA PSV — middle cerebral artery peak systolic velocity SVT — supraventricular tachycardia
MoM — multiples of the median CPAM — congenital pulmonary airway malformation
MDT — multidisciplinary team BPS — bronchopulmonary sequestration
CMV — cytomegalovirus EXIT — ex utero intrapartum treatment
PlGF — placental growth factor CTG — cardiotocography
Source: The Obstetrician & Gynaecologist (TOG), RCOG journal — doi:10.1111/tog.12862
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).